Cybin (HELP) Invested Capital (2021 - 2023)

Cybin (HELP) reported Invested Capital of $30.5 million for Q1 2023, up 1171.51% quarter-over-quarter from $2.4 million in Q4 2021.

Cybin (HELP) Invested Capital (2021 - 2023) Analysis & Trends

Cybin has reported Invested Capital for 2 years, with the latest figure at $30.5 million in Q1 2023.

For the quarter ending Q1 2023, Invested Capital changed N/A year-over-year to $30.5 million; the trailing twelve-month figure through Feb 2023 stood at $30.5 million (up 1034.91% YoY), and the FY2023 full-year result was $31.3 million, changed N/A from the prior year.
Invested Capital for Q1 2023 stood at $30.5 million, up from $2.4 million in the prior quarter.
The five-year high for Invested Capital was $68.9 million in Q1 2021, with the low at $288370.6 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	7.14 Bn
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	795.79 Mn
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	595,226.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	1.00 Bn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	14.38 Mn
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	19.36 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	502.95 Mn
10	Cybin	75.42 Mn	75.42 Mn	-	-

Download Data